---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-24-006793"
form_type: "8-K"
ticker: "ZEOX"
cik: "0001557376"
company_name: "Zeo ScientifiX, Inc."
filed_at: "2024-10-15T23:59:59+00:00"
generated_at: "2026-05-30T14:33:27.080110+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ZEO ScientifiX launches monthly regenerative medicine educational series for physicians

## Summary
- In-person events titled 'The Future of Biologic Medicine' focus on extracellular vesicles and autologous biologics.
- First event held early September 2024; second on October 4; next forum scheduled November 8, 2024 in Davie, FL.
- Events include expert-led discussions, lab tour at Nova Southeastern University, and regulatory overview.
- Company completed Phase 1 trials for flagship product Zofin and is seeking Phase 2 trials for multiple indications.
- Regenerative medicine market projected to reach ~$175B by 2032, 22.8% annual growth rate.

## SEC filing metadata
- accession: 0001829126-24-006793
- form_type: 8-K
- ticker: ZEOX
- cik: 0001557376
- company_name: Zeo ScientifiX, Inc.
- filed_at: 2024-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1557376/000182912624006793/0001829126-24-006793-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1557376/000182912624006793/zeoscientifix_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-24-006793
- JSON: https://secwatch.observer/filing/0001829126-24-006793.json
- Plain text: https://secwatch.observer/filing/0001829126-24-006793.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.